Sol-Gel Technologies (SLGL) Competitors $7.89 -0.22 (-2.66%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. CHEK, DRCT, FBRX, CLLS, CLYM, CABA, MCRB, TCRX, VNRX, and SRZNShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Check-Cap (CHEK), Direct Digital (DRCT), Forte Biosciences (FBRX), Cellectis (CLLS), Climb Bio (CLYM), Cabaletta Bio (CABA), Seres Therapeutics (MCRB), TScan Therapeutics (TCRX), VolitionRx (VNRX), and Surrozen (SRZN). Sol-Gel Technologies vs. Its Competitors Check-Cap Direct Digital Forte Biosciences Cellectis Climb Bio Cabaletta Bio Seres Therapeutics TScan Therapeutics VolitionRx Surrozen Sol-Gel Technologies (NASDAQ:SLGL) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability. Which has more risk and volatility, SLGL or CHEK? Sol-Gel Technologies has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Is SLGL or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -107.78%. Check-Cap's return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-107.78% -43.98% -35.28% Check-Cap N/A N/A N/A Which has higher valuation and earnings, SLGL or CHEK? Sol-Gel Technologies has higher revenue and earnings than Check-Cap. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$11.54M1.97-$10.58M-$4.70-1.73Check-CapN/AN/A-$17.57M-$3.00-0.26 Do analysts rate SLGL or CHEK? Sol-Gel Technologies presently has a consensus price target of $40.00, indicating a potential upside of 391.40%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Sol-Gel Technologies is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of SLGL or CHEK? 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to SLGL or CHEK? In the previous week, Sol-Gel Technologies had 1 more articles in the media than Check-Cap. MarketBeat recorded 2 mentions for Sol-Gel Technologies and 1 mentions for Check-Cap. Sol-Gel Technologies' average media sentiment score of 0.93 beat Check-Cap's score of 0.62 indicating that Sol-Gel Technologies is being referred to more favorably in the media. Company Overall Sentiment Sol-Gel Technologies Positive Check-Cap Positive SummarySol-Gel Technologies beats Check-Cap on 10 of the 15 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.71M$3.86B$5.52B$9.07BDividend YieldN/A1.17%5.25%4.02%P/E Ratio-1.736.6327.7220.26Price / Sales1.9711.58367.0678.98Price / CashN/A6.5037.4258.29Price / Book0.792.798.045.49Net Income-$10.58M-$109.62M$3.18B$250.27M7 Day Performance10.15%9.21%3.72%4.78%1 Month Performance17.63%11.60%3.72%7.20%1 Year Performance-4.68%22.08%29.92%17.27% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies2.7139 of 5 stars$8.14+0.4%$40.00+391.4%-5.3%$22.71M$11.54M-1.7350CHEKCheck-Cap0.321 of 5 stars$0.77+0.7%N/A-60.9%$4.48MN/A-0.2680DRCTDirect Digital2.937 of 5 stars$0.57+4.6%$6.00+961.9%-84.4%$10.21M$62.29M-0.3260Positive NewsFBRXForte Biosciences3.5531 of 5 stars$12.93+5.6%$61.00+371.8%+56,027.5%$80.65MN/A-0.795Positive NewsOptions VolumeGap DownCLLSCellectis3.388 of 5 stars$1.53+5.2%$4.00+162.3%-15.4%$80.60M$49.22M-1.77290CLYMClimb Bio3.5288 of 5 stars$1.24+5.1%$9.00+625.8%N/A$79.74MN/A-0.529News CoveragePositive NewsCABACabaletta Bio2.6862 of 5 stars$1.52-3.2%$14.43+849.2%-77.9%$79.67MN/A-0.6050Positive NewsGap UpMCRBSeres Therapeutics3.3581 of 5 stars$11.11+22.1%$73.67+563.1%-37.4%$79.46M$126.32M-2.42330Positive NewsHigh Trading VolumeTCRXTScan Therapeutics3.6418 of 5 stars$1.45+3.6%$7.80+437.9%-69.8%$79.23M$2.82M-1.33100Positive NewsVNRXVolitionRx2.2804 of 5 stars$0.76-9.3%$3.50+360.5%+7.3%$78.30M$1.31M-2.1180News CoverageAnalyst ForecastGap UpSRZNSurrozen2.2733 of 5 stars$8.94-0.9%$38.50+330.6%-11.4%$77.24M$10.65M-0.3680Positive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies Check-Cap Alternatives Direct Digital Alternatives Forte Biosciences Alternatives Cellectis Alternatives Climb Bio Alternatives Cabaletta Bio Alternatives Seres Therapeutics Alternatives TScan Therapeutics Alternatives VolitionRx Alternatives Surrozen Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
